Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Summary

The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.

Timeline

Start

2005-05

Primary completion

—

Completion

2005-07

Drugs

Indications